Contraception and reproductive planning during the COVID-19 pandemic

An interactive web-based dashboard to track COVID-19 in real time

(2020) Ensheng Dong et al.   LANCET INFECTIOUS DISEASES

The COVID‐19 epidemic

(2020) Thirumalaisamy P. Velavan et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Baricitinib exposure during pregnancy in rheumatoid arthritis

(2020) Giulia Costanzo et al.   Therapeutic Advances in Musculoskeletal Disease

Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells

(2020) Kimberly E Stelzig et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Thromboinflammation and the hypercoagulability of COVID‐19

(2020) Jean M. Connors et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Centring sexual and reproductive health and justice in the global COVID-19 response

(2020) Kelli Stidham Hall et al.   LANCET

Virtual health care in the era of COVID-19

(2020) Paul Webster   LANCET

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sexual and reproductive health (SRH): a key issue in the emergency response to the coronavirus disease (COVID- 19) outbreak

(2020) Kun Tang et al.   Reproductive Health

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

(2020) Isabel Ramírez et al.   MATURITAS

Implementation of reproductive life planning (RLP) in primary health care supported by an evidence-based website

(2019) Melinda Koo Andersson et al.   EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE

Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries

(2019) S. Bellizzi et al.   CONTRACEPTION

Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil

(2018) Luis Bahamondes et al.   CONTRACEPTION

Referral gynecological ambulatory clinic: principal diagnosis and distribution in health services

(2018) Adna Thaysa Marcial da Silva et al.   BMC Womens Health

Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model

(2018) Jonathan Bearak et al.   Lancet Global Health

Systematic review of efficacy with extending contraceptive implant duration

(2018) Lauren Thaxton et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Progestin-only contraception and thromboembolism: A systematic review

(2016) Naomi K. Tepper et al.   CONTRACEPTION

Hormonal contraception and thrombosis

(2016) Regine Sitruk-Ware   FERTILITY AND STERILITY

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant

(2016) Moazzam Ali et al.   HUMAN REPRODUCTION

High variability of hormonal levels and no clinically relevant interaction between ethinyl estradiol, desogestrel and lopinavir/ritonavir in a small sample of HIV-positive adolescents

(2016) Nadia Kancheva Landolt et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Committee Opinion No. 654

(2016)   OBSTETRICS AND GYNECOLOGY

It is time to prepare mental health services to attend to migrants and refugees

(2016) Lineth Hiordana Ugarte Bustamante et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study

(2016) Xiaohan Liu et al.   Interactive Cardiovascular and Thoracic Surgery

Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study

(2015) Amneris E. Luque et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Antiretroviral Therapy Including Lopinavir/Ritonavir or Efavirenz on Etonogestrel-Releasing Implant Pharmacokinetics in HIV-Positive Women

(2014) Carolina S. Vieira et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis

(2013) Xiaoping Zhang et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Can we reduce costs and prevent more unintended pregnancies? A cost of illness and cost-effectiveness study comparing two methods of EHC

(2013) Christine M Thomas et al.   BMJ Open

Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives

(2012) M. RAPS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Contraception and health

(2012) John Cleland et al.   LANCET

Preventing Unintended Pregnancies by Providing No-Cost Contraception

(2012) Jeffrey F. Peipert et al.   OBSTETRICS AND GYNECOLOGY

Influence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing Age

(2011) James H. Fischer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Interações medicamentosas: uma contribuição para o uso racional de imunossupressores sintéticos e biológicos

(2011) Luiza Cristina Lacerda Jacomini et al.   Revista Brasileira De Reumatologia